Targeted Therapy Shows Promise for Patients with Aggressive Meningiomas
January 16, 2026
January 16, 2026
BOSTON, Massachusetts, Jan. 16 [Category: BizHospital] -- Mass General Brigham issued the following news release:
* * *
Targeted Therapy Shows Promise for Patients with Aggressive Meningiomas
*
A national clinical trial led by investigators at Mass General Brigham Cancer Institute through the Alliance for Clinical Trials in Oncology, a leading NCI National Clinical Trials Network group, has found that abemaciclib, an oral cancer drug, may slow . . .
* * *
Targeted Therapy Shows Promise for Patients with Aggressive Meningiomas
*
A national clinical trial led by investigators at Mass General Brigham Cancer Institute through the Alliance for Clinical Trials in Oncology, a leading NCI National Clinical Trials Network group, has found that abemaciclib, an oral cancer drug, may slow . . .